Physician

Thanh J Van, MD

According to 2025 Medicare claims, Thanh Van, MD (NPI: 1548252430) practices radiation oncology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is HOUSTON METRO UROLOGY (NPI: 1245281922; TIN: 204473802) and primary practice location at 77027-6856.

Van's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 461 traditional Medicare patients, billed 20,685 HCPCS/CPT codes, and received $2,695,010 in Medicare payments. The top billing code was 77338 (Design and construction of radiation treatment device for high precision radiation therapy). Part D data shows 884 prescription claims across 404 beneficiaries totaling $126,558 in drug costs, led by Orgovyx (Relugolix). Open Payments data shows 17 records totaling $731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $13,622 to $126,558. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $2,415,122 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,922,972 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,029,170 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,633,626 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,431,168 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,293,158 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,347,027 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $989,811 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,273,165 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,695,010 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201557111,882$2,415,122
20163189,530$1,922,972
201743710,326$2,029,170
20185048,905$1,633,626
20194768,362$1,431,168
20204367,385$1,293,158
20214497,247$1,347,027
20224715,339$989,811
202349312,812$2,273,165
202446120,685$2,695,010

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$79K$157K2015 Drug cost: $13,622 (USD; Tot_Drug_Cst)2016 Drug cost: $8,750 (USD; Tot_Drug_Cst)2017 Drug cost: $13,255 (USD; Tot_Drug_Cst)2018 Drug cost: $12,752 (USD; Tot_Drug_Cst)2019 Drug cost: $13,658 (USD; Tot_Drug_Cst)2020 Drug cost: $12,254 (USD; Tot_Drug_Cst)2021 Drug cost: $8,280 (USD; Tot_Drug_Cst)2022 Drug cost: $15,083 (USD; Tot_Drug_Cst)2023 Drug cost: $157,440 (USD; Tot_Drug_Cst)2024 Drug cost: $126,558 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015132294$13,622
2016121254$8,750
2017144342$13,255
2018178491$12,752
2019205635$13,658
2020251737$12,254
2021243722$8,280
2022275570$15,083
2023335783$157,440
2024404884$126,558

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77338Design and construction of radiation treatment device for high precision radiation therapy186302$368
77263Complex radiation therapy planning177186$128
77334Design and construction of complex radiation treatment device176199$98
77336Continuing radiation therapy consultation per week174853$71
77300Calculation of radiation therapy dose1861,757$52

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OrgovyxRelugolix27810$73,460
Tamsulosin HclTamsulosin Hcl21010,856$1,973
Ciprofloxacin HclCiprofloxacin Hcl3181,391$1,216
SilodosinSilodosin23870$1,194
Megestrol AcetateMegestrol Acetate402,175$1,066

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$731Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thanh J. Van, MD?

Tedicare shows public-source Medicare data for Thanh J. Van, MD (NPI 1548252430), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thanh J. Van, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thanh J. Van, MD?

Thanh J. Van, MD is linked to HOUSTON METRO UROLOGY (billing NPI 1245281922) in the available physician profile data.

Does Thanh J. Van, MD have Open Payments data?

Thanh J. Van, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.